WHC+ (Women's Health CoOp PLUS) (NCT01497405) | Clinical Trial Compass
CompletedPhase 1
WHC+ (Women's Health CoOp PLUS)
United States, South Africa641 participantsStarted 2012-05
Plain-language summary
This study compares the effects of standard HIV test, treat and retain (TTR) practices with TTR plus a woman-focused enhanced strategy--Women's Health CoOp (WHC+) intervention) targeting hard-to-reach and vulnerable alcohol and other drug (AOD)-using women to determine if the WHC+ intervention is more efficacious than TTR alone in reducing HIV risk behavior. Additionally, the study will determine whether HIV positive women in the WHC+ arm are more likely to follow through with referrals for further medical evaluation and linkages to HIV treatment and other care than women in the TTR arm.
Who can participate
Age range15 Years – 55 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Female
✓. Black/African
✓. 15 years or older (if under 18, must be able to sign assent)
✓. Use at least one of the following drugs: alcohol, marijuana (dagga), methamphetamine (tik), Mandrax (methaqualone), cocaine (crack and/or powder), heroin (Thai White), inhalants (glue and benzene) methylenedioxymethamphetamine (MDMA -ecstasy), lysergic acid diethylamide (LSD), or Kat/cat, Nyaope (a mixture of marijuana and heroin) - weekly in the past 90 days
✓. Have had unprotected vaginal sex with a male partner in the last six months
✓. Able to speak English, Sesotho, Tswana, or Zulu
✓. Consent to HIV rapid testing and drug testing
✓. Provide written verbal and assent/consent to participate